ResMed's Fourth-Quarter EPS Rises

San Diego-based ResMed ( RMD) reported fourth-quarter earnings that beat analysts' estimates by 1 cent. Revenue was also up 20% from last year on strong-demand for its anti-snoring devices.

ResMed's earnings were $9.8 million, or 29 cents a share, compared with First Call/Thomson Financial's estimates of 28 cents. The $9.8 million net income was up from last year's earnings of $8.3 million, or 25 cents a share. ResMed develops devices to diagnosis and treat sleep-disordered breathing.

Revenue rose to $56.2 million from $47 million a year ago.

The EPS increase was due to stronger markets for the company's sleep-disordered breathing products. ResMed said domestic sales rose 27% to $28.4 million in the quarter while foreign sales rose 13% year-over-year.

Analysts surveyed by First Call are predicting ResMed's earnings to be 28 cents a share in the first quarter of 2002.

More from Technology

These 5 Tech Giants Still Aren't That Expensive

These 5 Tech Giants Still Aren't That Expensive

Intel CEO Brian Krzanich's Ouster Proves CEOs Aren't Above the Rules

Intel CEO Brian Krzanich's Ouster Proves CEOs Aren't Above the Rules

Amazon, Microsoft and Google Face Backlash over ICE, Military Deals

Amazon, Microsoft and Google Face Backlash over ICE, Military Deals

As Intel Loses Its CEO, How Well Can It Compete Against Nvidia?

As Intel Loses Its CEO, How Well Can It Compete Against Nvidia?

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In